Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis
Irene Tramacere(Fondazione IRCCS Istituto Neurologico Carlo Besta), Graziella Filippini(Oldham Council), Ilaria Pacchetti(Fondazione IRCCS Istituto Neurologico Carlo Besta), Roberto D’Amico(University of Modena and Reggio Emilia), Cinzia Del Giovane(University of Modena and Reggio Emilia), Georgia Salanti(University of Bern)
Cited by 41
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k